Skip to main content

Table 2 Tumor response after radiotherapy

From: Trimodality bladder-sparing approach without neoadjuvant chemotherapy for node-negative localized muscle-invasive urinary bladder cancer resulted in comparable cystectomy-free survival

 

Evaluable patients (n = 64)

Complete response (CR)

50 (78.1%)

Partial response (PR)

2 (3.1%)

Stable disease (SD)

3 (4.7%)

Progressive disease (PD)

9 (14.1%)